PEUSstudy
Phase 4
Recruiting
- Conditions
- pancreatobiliary disease
- Registration Number
- JPRN-jRCTs071180072
- Lead Sponsor
- ueki toshiharu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Admitted patients with suspected pancreatobiliary tumor at departoment of gastroenterology in Fukuoka University Chikushi Hospital
Exclusion Criteria
Patients who fall under one or more of the following exclusion criteria are not included.
(1) Patients with a history of hypersensitivity to the ingredients of this drug
(2) Patients with are allergic to eggs or egg products
(3) Patients with an arteriovenous (right and left) shunt in the heart and lungs
(4) Patients with severe heart disease
(5) patients with severe lung disease
(6) Patients with the doctor in charge deems inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Differential diagnosis of patients with suspected biliary and pancreatic tumors by contrasting pattern after administration of perflubutanein
- Secondary Outcome Measures
Name Time Method Determine the therapeutic effect of biliary tract cancer/oancreatic cancer after chemotharapy by administration of perflubutanein